Advertisement

Brachytherapy outcome modeling in cervical cancer patients: A predictive machine learning study on patient-specific clinical, physical and dosimetric parameters

      Abstract

      Purpose

      To predict clinical response in locally advanced cervical cancer (LACC) patients by a combination of measures, including clinical and brachytherapy parameters and several machine learning (ML) approaches.

      Methods

      Brachytherapy features such as insertion approaches, source metrics, dosimetric, and clinical measures were used for modeling. Four different ML approaches, including LASSO, Ridge, support vector machine (SVM), and Random Forest (RF), were applied to extracted measures for model development alone or in combination. Model performance was evaluated using the area under the curve (AUC) of receiver operating characteristics curve, sensitivity, specificity, and accuracy. Our results were compared with a reference model developed by simple logistic regression applied to three distinct clinical features identified by previous papers.

      Results

      One hundred eleven LACC patients were included. Nine data sets were obtained based on the features, and 36 predictive models were built. In terms of AUC, the model developed using RF applied to dosimetric, physical, and total BT sessions features were found as the most predictive [AUC; 0.82 (0.95 confidence interval (CI); 0.79 –0.93), sensitivity; 0.79, specificity; 0.76, and accuracy; 0.77]. The AUC (0.95 CI), sensitivity, specificity, and accuracy for the reference model were found as 0.56 (0.52 −0.68), 0.51, 0.51, and 0.48, respectively. Most RF models had significantly better performance than the reference model (Bonferroni corrected p-value < 0.0014).

      Conclusion

      Brachytherapy response can be predicted using dosimetric and physical parameters extracted from treatment parameters. Machine learning algorithms, including Random Forest, could play a critical role in such predictive modeling.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brachytherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Vu M
        • Yu J
        • Awolude OA
        • Chuang L.
        Cervical cancer worldwide.
        Curr Probl Cancer. 2018; 42: 457-465
        • Ch PN
        • Gurram L
        • Chopra S
        • Mahantshetty U.
        The management of locally advanced cervical cancer.
        Curr Opin Oncol. 2018; 30: 323-329
        • Tanderup K
        • Eifel PJ
        • Yashar CM
        • et al.
        Curative radiation therapy for locally advanced cervical cancer: brachytherapy is NOT optional.
        Int J Radiat Oncol Biol Phys. 2014; 88: 537-539
        • Chargari C
        • Deutsch E
        • Blanchard P
        • et al.
        Brachytherapy: An overview for clinicians.
        CA Cancer J Clin. 2019; 69: 386-401
        • Sturdza A
        • Pötter R
        • Fokdal LU
        • et al.
        Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.
        Radiother Oncol. 2016; 120: 428-433
        • Tanderup K
        • Fokdal LU
        • Sturdza A
        • et al.
        Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
        Radiather Oncol. 2016; 120: 441-446
        • Lee HJ
        • Kim JM
        • Chin YJ
        • et al.
        Prognostic value of hematological parameters in locally advanced cervical cancer patients treated with concurrent chemoradiotherapy.
        Anticancer Res. 2020; 40: 451-458
        • Kallis K
        • Mayadev J
        • Kisling K
        • et al.
        Knowledge-based dose prediction models to inform gynecologic brachytherapy needle supplementation for locally advanced cervical cancer.
        Brachytherapy. 2021; 20: 1187-1199
        • Pötter R
        • Georg P
        • Dimopoulos JC
        • et al.
        Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer.
        Radiother Oncol. 2011; 100: 116-123
        • Fu J
        • Wang W
        • Wang Y
        • et al.
        The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer.
        Radiat Oncol. 2019; 14: 1-5
        • Wagenaar H
        • Trimbos J
        • Postema S
        • et al.
        Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
        Gynecol Oncol. 2001; 82: 474-482
        • Dimopoulos JC
        • Lang S
        • Kirisits C
        • et al.
        Dose–volume histogram parameters and local tumor control in magnetic resonance image–guided cervical cancer brachytherapy.
        Int J Radiat Oncol Biol Phys. 2009; 75: 56-63
        • Wang M
        • Gu H
        • Hu J
        • et al.
        Evaluation of a highly refined prediction model in knowledge-based volumetric modulated arc therapy planning for cervical cancer.
        Radiat Oncol. 2021; 16: 1-10
        • Shim S-H
        • Lee S-W
        • Park J-Y
        • et al.
        Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy.
        Gynecol Oncol. 2013; 128: 54-59
        • Tseng J-Y
        • Yen M-S
        • Twu N-F
        • et al.
        Prognostic nomogram for overall survival in stage IIB-IVA cervical cancer patients treated with concurrent chemoradiotherapy.
        Am J Obstet Gynecol. 2010; 202 (e1-. e7): 174.
        • Shiri I
        • Akhavanallaf A
        • Sanaat A
        • et al.
        Ultra-low-dose chest CT imaging of COVID-19 patients using a deep residual neural network.
        Eur Radiol. 2021; 31: 1420-1431
        • Abdollahi H
        • Tanha K
        • Mofid B
        • et al.
        MRI radiomic analysis of IMRT-induced bladder wall changes in prostate cancer patients: a relationship with radiation dose and toxicity.
        J Med Imaging Radiat Sci. 2019; 50: 252-260
        • Abdollahi H
        • Mahdavi SR
        • Shiri I
        • et al.
        Magnetic resonance imaging radiomic feature analysis of radiation-induced femoral head changes in prostate cancer radiotherapy.
        J Cancer Res Ther. 2019; 15: S11-S19
        • Lu J
        • Song E
        • Ghoneim A
        • Alrashoud M.
        Machine learning for assisting cervical cancer diagnosis: an ensemble approach.
        Future Gener Comput Syst. 2020; 106: 199-205
        • Alyafeai Z
        • Ghouti L
        A fully-automated deep learning pipeline for cervical cancer classification.
        Expert Syst Appl. 2020; 141112951
        • Tseng C-J
        • Lu C-J
        • Chang C-C
        • Chen G-D.
        Application of machine learning to predict the recurrence-proneness for cervical cancer.
        Neural Comput Appl. 2014; 24: 1311-1316
        • Arezzo F
        • La Forgia D
        • Venerito V
        • et al.
        A machine learning tool to predict the response to neoadjuvant chemotherapy in patients with locally advanced cervical cancer.
        Appl Sci. 2021; 11: 823
        • Zhen X
        • Chen J
        • Zhong Z
        • et al.
        Deep convolutional neural network with transfer learning for rectum toxicity prediction in cervical cancer radiotherapy: a feasibility study.
        Phys Med Biol. 2017; 62: 8246
        • Katz A
        • Eifel PJ.
        Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix.
        Int J Radiat Oncol Biol Phys. 2000; 48: 1417-1425
        • Viswanathan AN
        • Moughan J
        • Small W
        • et al.
        The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128.
        Int J Gynecol Cancer. 2012; 22: 123-131
        • Dimopoulos JC
        • Petrow P
        • Tanderup K
        • et al.
        Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): basic principles and parameters for mr imaging within the frame of image based adaptive cervix cancer brachytherapy.
        Radiather Oncol. 2012; 103: 113-122
        • Haie-Meder C
        • Pötter R
        • Van Limbergen E
        • et al.
        Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆(I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.
        Radiother Oncol. 2005; 74: 235-245
        • Pötter R
        • Haie-Meder C
        • Van Limbergen E
        • et al.
        Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
        Radiother Oncol. 2006; 78: 67-77
        • Viswanathan AN
        • Beriwal S
        • Jennifer F
        • et al.
        American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy.
        Brachytherapy. 2012; 11: 47-52
        • De Kerf G
        • Van Gestel D
        • Mommaerts L
        • et al.
        Evaluation of the optimal combinations of modulation factor and pitch for Helical TomoTherapy plans made with TomoEdge using Pareto optimal fronts.
        Radiat Oncol. 2015; 10: 1-7
        • Jones B
        • Dale R
        • Deehan C
        • et al.
        The role of biologically effective dose (BED) in clinical oncology.
        Clin Oncol. 2001; 13: 71-81
        • Nag S
        • Gupta N.
        A simple method of obtaining equivalent doses for use in HDR brachytherapy.
        Int J Radiat Oncol Biol Phys. 2000; 46: 507-513
        • Jeong YY
        • Kang HK
        • Chung TW
        • et al.
        Uterine cervical carcinoma after therapy: CT and MR imaging findings.
        Radiographics. 2003; 23: 969-981
        • Jalaguier-Coudray A
        • Villard-Mahjoub R
        • Delouche A
        • et al.
        Value of dynamic contrast-enhanced and diffusion-weighted MR imaging in the detection of pathologic complete response in cervical cancer after neoadjuvant therapy: a retrospective observational study.
        Radiology. 2017; 284: 432-442
        • Nakao Y
        • Tamauchi S
        • Yoshikawa N
        • et al.
        Complete response of recurrent small cell carcinoma of the uterine cervix to paclitaxel, carboplatin, and bevacizumab combination therapy.
        Case Rep Oncol. 2020; 13: 373-378
        • Das S
        • Chandramohan A
        • Reddy JKR
        • et al.
        Role of conventional and diffusion weighted MRI in predicting treatment response after low dose radiation and chemotherapy in locally advanced carcinoma cervix.
        Radiother Oncol. 2015; 117: 288-293
        • Choong ES
        • Bownes P
        • Musunuru HB
        • et al.
        Hybrid (CT/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: dosimetry comparisons and clinical outcome.
        Brachytherapy. 2016; 15: 40-48
        • Chargari C
        • Magné N
        • Dumas I
        • et al.
        Physics contributions and clinical outcome with 3D-MRI–based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
        Int J Radiat Oncol Biol Phys. 2009; 74: 133-139
        • Kalash R
        • Glaser SM
        • Rangaswamy B
        • et al.
        Use of functional magnetic resonance imaging in cervical cancer patients with incomplete response on positron emission tomography/computed tomography after image-based high-dose-rate brachytherapy.
        Int J Radiat Oncol Biol Phys. 2018; 102: 1008-1013
      1. Lives S. Cervical Cancer. 2022

        • Tibshirani R.
        Regression shrinkage and selection via the lasso.
        J R Stat Soc Ser B. 1996; 58: 267-288
        • Fonti V
        • Belitser E.
        Feature selection using lasso.
        VU Amsterdam Res Paper Busin Analyt. 2017; 30: 1-25
        • Park YW
        • Choi D
        • Park JE
        • et al.
        Differentiation of recurrent glioblastoma from radiation necrosis using diffusion radiomics with machine learning model development and external validation.
        Sci Rep. 2021; 11: 1-9
        • Sokolova M
        • Lapalme G.
        A systematic analysis of performance measures for classification tasks.
        Inf Process Manag. 2009; 45: 427-437
        • Schernberg A
        • Bockel S
        • Annede P
        • et al.
        Tumor shrinkage during chemoradiation in locally advanced cervical cancer patients: prognostic significance, and impact for image-guided adaptive brachytherapy.
        Int J Radiat Oncol Biol Phys. 2018; 102: 362-372
        • Tiwari R
        • Narayanan GS
        • Narayanan S
        • Kumar PS.
        Long-term effectiveness and safety of image-based, transperineal combined intracavitary and interstitial brachytherapy in treatment of locally advanced cervical cancer.
        Brachytherapy. 2020; 19: 73-80
        • Bonferroni C.
        Teoria statistica delle classi e calcolo delle probabilita.
        Pubblicazioni del R Istituto Superiore di Scienze Economiche e Commericiali di Firenze. 1936; 8: 3-62
        • Liu Z
        • Zhao Y
        • Li Y
        • et al.
        Imaging-guided brachytherapy for locally advanced cervical cancer: the main process and common techniques.
        Am J Cancer Res. 2020; 10: 4165
        • Legge F
        • Chiantera V
        • Macchia G
        • et al.
        Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies.
        Gynecol Oncol. 2015; 138: 83-88
        • le Guyader M
        • Kee DLC
        • Thamphya B
        • et al.
        High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes.
        Clin Transl Radiat Oncol. 2022; 32: 15-23
        • Nag S
        • Erickson B
        • Thomadsen B
        • et al.
        The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix.
        Int J Radiat Oncol Biol Phys. 2000; 48: 201-211
        • Fionda B
        • Boldrini L
        • D'Aviero A
        • et al.
        Artificial intelligence (AI) and interventional radiotherapy (brachytherapy): state of art and future perspectives.
        J Contemp Brachytherapy. 2020; 12: 497
        • Abdollahi H
        • Mostafaei S
        • Cheraghi S
        • et al.
        Cochlea CT radiomics predicts chemoradiotherapy induced sensorineural hearing loss in head and neck cancer patients: a machine learning and multi-variable modelling study.
        Physica Medica. 2018; 45: 192-197
        • Mostafaei S
        • Abdollahi H
        • Kazempour Dehkordi S
        • et al.
        CT imaging markers to improve radiation toxicity prediction in prostate cancer radiotherapy by stacking regression algorithm.
        Radiol Med. 2020; 125: 87-97
        • Mahantshetty U
        • Krishnatry R
        • Hande V
        • et al.
        Magnetic resonance image guided adaptive brachytherapy in locally advanced cervical cancer: an experience from a tertiary cancer center in a low and middle income countries setting.
        Int J Radiat Oncol Biol Phys. 2017; 99: 608-617
        • Lakosi F
        • de Cuypere M
        • Viet Nguyen P
        • et al.
        Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: a mono-institutional experience.
        Act Oncol. 2015; 54: 1558-1566
        • Amini M
        • Nazari M
        • Shiri I
        • et al.
        Multi-level multi-modality (PET and CT) fusion radiomics: prognostic modeling for non-small cell lung carcinoma.
        Phys Med Biol. 2021; 66205017
        • Deist TM
        • Dankers FJ
        • Valdes G
        • et al.
        Machine learning algorithms for outcome prediction in (chemo) radiotherapy: an empirical comparison of classifiers.
        Med Phys. 2018; 45: 3449-3459
        • Nazari M
        • Shiri I
        • Hajianfar G
        • et al.
        Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning.
        Radiol Med. 2020; 125: 754-762
        • Hu C
        • Steingrimsson JA.
        Personalized risk prediction in clinical oncology research: applications and practical issues using survival trees and random forests.
        J Biopharm Stat. 2018; 28: 333-349
        • Huang J
        • Ling CX.
        Using AUC and accuracy in evaluating learning algorithms.
        IEEE Trans Knowl Data Eng. 2005; 17: 299-310
        • Andersen PK
        3. Applied logistic regression.
        2nd edn. Wiley, New York2000 (David W. Hosmer and Stanley LemeshowNo. of pages: xii+ 373. Price:£ 60.95. ISBN 0-471-35632-8. John Wiley & Sons, Ltd. Chichester, UK; 2002)
        • Wang H
        • Zhou Z
        • Li Y
        • et al.
        Comparison of machine learning methods for classifying mediastinal lymph node metastasis of non-small cell lung cancer from 18F-FDG PET/CT images.
        EJNMMI Res. 2017; 7: 1-11
        • Caballo M
        • Sanderink WB
        • Han L
        • et al.
        Four-dimensional machine learning radiomics for the pretreatment assessment of breast cancer pathologic complete response to neoadjuvant chemotherapy in dynamic contrast-enhanced MRI.
        J Magn Reson Imaging. 2022;
        • Belabbas M-A
        • Wolfe PJ.
        Spectral methods in machine learning and new strategies for very large datasets.
        Proc Natl Acad Sci USA. 2009; 106: 369-374
        • Lindegaard JC
        • Petric P
        • Schmid MP
        • et al.
        Prognostic implications of uterine cervical cancer regression during chemoradiation evaluated by the T-Score in the multicenter EMBRACE I Study.
        Int J Radiat Oncol Biol Phys. 2022; 113: 379-389
        • Hulsen T
        • Jamuar SS
        • Moody AR
        • et al.
        From big data to precision medicine.
        Front Med. 2019; 6: 34
        • Luo Y
        • Chen S
        • Valdes G
        Machine learning for radiation outcome modeling and prediction.
        Med Phys. 2020; 47 (-e84): e178
        • Bibault J-E
        • Giraud P
        • Burgun A
        Big data and machine learning in radiation oncology: state of the art and future prospects.
        Cancer Lett. 2016; 382: 110-117
        • Tan L
        • Coles C
        • Hart C
        • Tait E.
        Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator—the Addenbrooke's experience.
        Clin Oncol. 2009; 21: 175-182